Immediate Impact

1 from Science/Nature 80 standout
Sub-graph 1 of 22

Citing Papers

The hallmarks of cancer immune evasion
2024 Standout
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
4 intermediate papers

Works of Maggie Wilcox being referenced

Abstract GS1-03: Peri-operative aromatase inhibitor treatment in determining or predicting longterm outcome in early breast cancer – The POETIC* Trial (CRUK/07/015)
2018
Chemotherapy and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2–Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
2014
and 1 more

Author Peers

Author Last Decade Papers Cites
Maggie Wilcox 295 329 21 162 9 496
EC Inwald 249 256 15 92 11 494
Amy Krie 262 254 12 168 10 504
Pankaj Khandelwal 226 388 13 111 10 547
Alisha Stein 143 319 11 163 14 431
Khémaies Slimane 233 275 7 175 18 436
Ninad Dewal 288 190 27 193 9 489
Fatemeh Lorenz-Salehi 244 312 7 170 17 419
BC Lembersky 157 291 8 169 14 437
Nancy G. Iskander 292 217 6 198 5 423
Christian Löhberg 251 309 22 103 10 522

All Works

Loading papers...

Rankless by CCL
2026